Bile acids and gut peptide secretion after bariatric surgery: A 1-year prospective randomized pilot trial

Obesity

Volumn 21, Issue 12, 2013, Pages

  Steinert, Robert E ^a   Peterli, Ralph ^b,c   Keller, Sylvia ^d   Meyer Gerspach, Anne C ^a   Drewe, Jürgen ^a   Peters, Thomas ^c   Beglinger, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c St Claraspital AG   (Switzerland)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY;

ADULT; ARTICLE; BARIATRIC SURGERY; BILE ACID BLOOD LEVEL; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCEMIC CONTROL; HUMAN; LAPAROSCOPIC SURGERY; OBESITY; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS;

ADULT; BILE ACIDS AND SALTS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; GASTRECTOMY; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; OBESITY, MORBID; PEPTIDE YY; PILOT PROJECTS; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES;

EID: 84889688521     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20522     Document Type: Article

References (38)

1. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K,. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 2008; 7: 678-693.
2. Katsuma S, Hirasawa A, Tsujimoto G,. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005; 329: 386-390.
3. Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, Gribble FM,. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol 2012; 165: 414-423.
4. Holst JJ,. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
5. Steinert RE, Feinle-Bisset C, Geary N, Beglinger C,. Secretion of gastrointestinal hormones and eating control. J Anim Sci 2013; 91: 1963-1973.
6. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10: 167-177.
7. Adrian TE, Gariballa S, Parekh KA, et al. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia 2012; 55: 2343-2347.
8. Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012; 153: 3613-3619.
9. Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H,. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metab Clin Exp 2009; 58: 1400-1407.
10. Simonen M, Dali-Youcef N, Kaminska D, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012; 22: 1473-1480.
11. Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009; 17: 1671-1677.
12. Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 2012; 22: 740-748.
13. Ahlberg J, Angelin B, Bjorkhem I, Einarsson K,. Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology 1977; 73: 1377-1382.
14. Angelin B, Bjorkhem I,. Postprandial serum bile acids in healthy man: evidence for differences in absorptive pattern between individual bile acids. Gut 1977; 18: 606-609.
15. Angelin B, Bjorkhem I, Einarsson K, Ewerth S,. Hepatic uptake of bile acids in man: fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest 1982; 70: 724-731.
16. Gerspach AC, Steinert RE, Schonenberger L, Graber-Maier A, Beglinger C,. The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans. Am J Physiol Endocrinol Metab 2011; 301: E317-E325.
17. Steinert R, Poller B, Castelli M, et al. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects. Clin Pharmacol Ther 2009; 86: 644-650.
18. Keller S, Jahreis G,. Determination of underivatised sterols and bile acid trimethyl silyl ether methyl esters by gas chromatography-mass spectrometry-single ion monitoring in faeces. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 813: 199-207.
19. Scherer M, Gnewuch C, Schmitz G, Liebisch G,. Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 3920-3925.
20. Xiang X, Han Y, Neuvonen M, Laitila J, Neuvonen PJ, Niemi M,. High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 51-60.
21. Tagliacozzi D, Mozzi AF, Casetta B, et al. Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin Chem Lab Med 2003; 41: 1633-1641.
22. Bentayeb K, Batlle R, Sánchez C, Nerín C, Domeño C,. Determination of bile acids in human serum by on-line restricted access material-ultra high-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 869: 1-8.
23. Bland JM, Altman DG,. Calculating correlation coefficients with repeated observations: Part 2-Correlation between subjects. BMJ 1995; 310: 633.
24. Bland JM, Altman DG,. Calculating correlation coefficients with repeated observations: Part 1-Correlation within subjects. BMJ 1995; 310: 446.
25. Kohli R, Kirby M, Setchell KD, et al. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol 2010; 299: G652-G660.
26. Strader AD, Clausen TR, Goodin SZ, Wendt D,. Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats. Obes Surg 2009; 19: 96-104.
27. Rafferty EP, Wylie AR, Hand KH, Elliott CE, Grieve DJ, Green BD,. Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R(-/-) mice. Biol Chem 2011; 392: 539-546.
28. Wu T, Bound MJ, Standfield SD, Jones KL, Horowitz M, Rayner CK,. Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans. J Clin Endocrinol Metab 2013; 98: E718-E722.
29. Meyer-Gerspach AC, Steinert RE, Keller S, Malarski A, Schulte FH, Beglinger C,. Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans. J Clin Endocrinol Metab 2013 Jun 19. doi: 10.1210/jc.2012-4109. [Epub ahead of print]
30. Ma K, Saha PK, Chan L, Moore DD,. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 2006; 116: 1102-1109.
31. Kir S, Beddow SA, Samuel VT, et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 2011; 331: 1621-1624.
32. Brufau G, Bahr MJ, Staels B, et al. Plasma bile acids are not associated with energy metabolism in humans. Nutr Metab (Lond) 2010; 7: 73.
33. Brufau G, Stellaard F, Prado K, et al. Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism. Hepatology 2010; 52: 1455-1464.
34. Glicksman C, Pournaras DJ, Wright M, et al. Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 2010; 47: 482-484.
35. Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbely Y, Beglinger C,. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial. Surg Obes Relat Dis 2011; 7: 561-568.
36. Boden G, Chen X, Mozzoli M, Ryan I,. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996; 81: 3419-3423.
37. de Castro Cesar M, de Lima Montebelo MI, Rasera I, Jr, de Oliveira AV, Jr, Gomes Gonelli PR, Aparecida Cardoso G,. Effects of Roux-en-Y gastric bypass on resting energy expenditure in women. Obes Surg 2008; 18: 1376-1380.
38. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K,. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 2008; 7: 678-693.